Clover Health Investments Stock EBITDA

CLOV Stock

USD 2.78 0.11 3.81%

Fundamental analysis of Clover Health allows traders to better anticipate movements in Clover Health's stock price by examining its financial health and performance throughout various phases of its business cycle.

		Last Reported	Projected for Next Year
	EBITDA	-44.9 M	-47.2 M

EBITDA is likely to drop to about (47.2 M) in 2025.

Build AI portfolio with Clover Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Clover Health Investments Company EBITDA Analysis

Clover Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Clover Health EBITDA

(44.94 M)

Most of Clover Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clover Health Investments is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Clover EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Clover Health is extremely important. It helps to project a fair market value of Clover Stock properly, considering its historical fundamentals such as EBITDA. Since Clover Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Clover Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Clover Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Invested Capital	Net Working Capital	Current Deferred Revenue	Long Term Debt	Short Term Investments	Long Term Investments	Short Long Term Debt	Capital Stock	Short Term Debt
Total Assets		0.78	0.9	-0.88	-0.84	-0.8	0.89	0.37	0.97	0.53	-0.09	0.43	0.38	0.65	0.95	-0.04	-0.9	0.48	0.85	-0.28	-0.91	-0.9
Total Stockholder Equity	0.78		0.89	-0.83	-0.86	-0.49	0.62	-0.26	0.86	0.39	-0.62	0.36	0.19	0.15	0.84	-0.22	-0.85	0.25	0.82	-0.42	-0.85	-0.85
Net Tangible Assets	0.9	0.89		-0.91	-0.97	-0.81	0.87	0.12	0.91	0.47	-0.24	0.61	0.21	0.52	0.89	-0.4	-1.0	0.15	0.94	-0.55	-1.0	-1.0
Net Debt	-0.88	-0.83	-0.91		0.83	0.76	-0.72	-0.19	-0.87	-0.2	0.15	-0.49	0.02	-0.6	-0.93	0.26	0.89	-0.23	-0.94	0.54	0.89	0.88
Retained Earnings	-0.84	-0.86	-0.97	0.83		0.71	-0.81	-0.08	-0.83	-0.47	0.31	-0.47	-0.2	-0.4	-0.78	0.51	0.96	0.0	-0.9	0.57	0.96	0.97
Accounts Payable	-0.8	-0.49	-0.81	0.76	0.71		-0.93	-0.55	-0.77	-0.43	-0.35	-0.81	-0.23	-0.9	-0.76	0.29	0.85	-0.18	-0.8	0.4	0.85	0.85
Net Receivables	0.89	0.62	0.87	-0.72	-0.81	-0.93		0.47	0.88	0.67	0.14	0.69	0.49	0.75	0.81	-0.19	-0.9	0.31	0.78	-0.32	-0.9	-0.9
Total Liab	0.37	-0.26	0.12	-0.19	-0.08	-0.55	0.47		0.2	0.25	0.82	0.17	0.23	0.81	0.21	0.12	-0.18	0.2	0.13	-0.06	-0.18	-0.18
Total Current Assets	0.97	0.86	0.91	-0.87	-0.83	-0.77	0.88	0.2		0.54	-0.21	0.49	0.4	0.56	0.97	0.0	-0.91	0.53	0.83	-0.25	-0.91	-0.9
Intangible Assets	0.53	0.39	0.47	-0.2	-0.47	-0.43	0.67	0.25	0.54		-0.08	0.34	0.93	0.25	0.35	0.14	-0.49	0.28	0.37	-0.13	-0.49	-0.5
Common Stock	-0.09	-0.62	-0.24	0.15	0.31	-0.35	0.14	0.82	-0.21	-0.08		0.27	-0.04	0.68	-0.17	0.07	0.17	-0.03	-0.16	0.09	0.17	0.17
Property Plant Equipment	0.43	0.36	0.61	-0.49	-0.47	-0.81	0.69	0.17	0.49	0.34	0.27		0.15	0.63	0.48	-0.37	-0.63	-0.05	0.61	-0.39	-0.63	-0.64
Good Will	0.38	0.19	0.21	0.02	-0.2	-0.23	0.49	0.23	0.4	0.93	-0.04	0.15		0.13	0.21	0.45	-0.23	0.49	0.11	0.22	-0.24	-0.24
Net Invested Capital	0.65	0.15	0.52	-0.6	-0.4	-0.9	0.75	0.81	0.56	0.25	0.68	0.63	0.13		0.6	-0.07	-0.57	0.26	0.56	-0.23	-0.57	-0.56
Net Working Capital	0.95	0.84	0.89	-0.93	-0.78	-0.76	0.81	0.21	0.97	0.35	-0.17	0.48	0.21	0.6		-0.02	-0.88	0.53	0.84	-0.28	-0.88	-0.87
Current Deferred Revenue	-0.04	-0.22	-0.4	0.26	0.51	0.29	-0.19	0.12	0.0	0.14	0.07	-0.37	0.45	-0.07	-0.02		0.41	0.8	-0.4	0.69	0.4	0.42
Long Term Debt	-0.9	-0.85	-1.0	0.89	0.96	0.85	-0.9	-0.18	-0.91	-0.49	0.17	-0.63	-0.23	-0.57	-0.88	0.41		-0.13	-0.94	0.54	1.0	1.0
Short Term Investments	0.48	0.25	0.15	-0.23	0.0	-0.18	0.31	0.2	0.53	0.28	-0.03	-0.05	0.49	0.26	0.53	0.8	-0.13		0.06	0.57	-0.15	-0.12
Long Term Investments	0.85	0.82	0.94	-0.94	-0.9	-0.8	0.78	0.13	0.83	0.37	-0.16	0.61	0.11	0.56	0.84	-0.4	-0.94	0.06		-0.59	-0.94	-0.94
Short Long Term Debt	-0.28	-0.42	-0.55	0.54	0.57	0.4	-0.32	-0.06	-0.25	-0.13	0.09	-0.39	0.22	-0.23	-0.28	0.69	0.54	0.57	-0.59		0.53	0.54
Capital Stock	-0.91	-0.85	-1.0	0.89	0.96	0.85	-0.9	-0.18	-0.91	-0.49	0.17	-0.63	-0.24	-0.57	-0.88	0.4	1.0	-0.15	-0.94	0.53		1.0
Short Term Debt	-0.9	-0.85	-1.0	0.88	0.97	0.85	-0.9	-0.18	-0.9	-0.5	0.17	-0.64	-0.24	-0.56	-0.87	0.42	1.0	-0.12	-0.94	0.54	1.0

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Clover Health

Ebitda Over Time

Clover Ebitda

Ebitda

(47.18 Million)

Clover Health reported EBITDA of (44.94 Million) in 2024

According to the company disclosure, Clover Health Investments reported earnings before interest,tax, depreciation and amortization of (44.94 Million). This is 105.12% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 101.15% higher than that of the company.

Clover EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clover Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clover Health could also be used in its relative valuation, which is a method of valuing Clover Health by comparing valuation metrics of similar companies.

Clover Health is currently under evaluation in ebitda category among its peers.

Clover Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of Clover Health from analyzing Clover Health's financial statements. These drivers represent accounts that assess Clover Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Clover Health's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	6.8B	1.8B	442.7M	459.1M	1.5B	2.4B
Enterprise Value	6.8B	1.5B	344.7M	340.9M	1.3B	2.3B

Clover Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clover Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clover Health's managers, analysts, and investors.

Environmental

Governance

Social

Clover Health Institutional Holders

Institutional Holdings refers to the ownership stake in Clover Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Clover Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Clover Health's value.

		Shares
Goldman Sachs Group Inc	2025-03-31	2.2 M
Susquehanna International Group, Llp	2025-03-31	2.2 M
Citadel Advisors Llc	2025-03-31	1.7 M
Jane Street Group Llc	2025-03-31	1.3 M
Gmt Capital Corp	2025-03-31	1.3 M
Bank Of America Corp	2025-03-31	1.3 M
Amvescap Plc.	2025-03-31	1.2 M
Northern Trust Corp	2025-03-31	1 M
American Century Companies Inc	2025-03-31	886.6 K
Vanguard Group Inc	2025-03-31	20.6 M
Renaissance Technologies Corp	2025-03-31	11 M

Clover Fundamentals

	Return On Equity	-0.0775
	Return On Asset	-0.0243
	Profit Margin	(0.02) %
	Operating Margin	(0) %
	Current Valuation	1.08 B
	Shares Outstanding	416.54 M
	Shares Owned By Insiders	3.77 %
	Shares Owned By Institutions	26.37 %
	Number Of Shares Shorted	36.2 M
	Price To Book	4.19 X
	Price To Sales	0.99 X
	Revenue	1.37 B
	Gross Profit	391.93 M
	EBITDA	(44.94 M)
	Net Income	(43.01 M)
	Cash And Equivalents	711.78 M
	Cash Per Share	1.49 X
	Total Debt	239.6 M
	Debt To Equity	0.07 %
	Current Ratio	1.29 X
	Book Value Per Share	0.66 X
	Cash Flow From Operations	34.84 M
	Short Ratio	2.92 X
	Earnings Per Share	(0.04) X
	Price To Earnings To Growth	(0.08) X
	Target Price	4.69
	Number Of Employees	570
	Beta	1.87
	Market Capitalization	1.48 B
	Total Asset	580.74 M
	Retained Earnings	(2.2 B)
	Working Capital	129.61 M
	Net Asset	580.74 M

About Clover Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Clover Health Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clover Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clover Health Investments based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clover Stock Analysis

When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC